IL68497A0 - Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them - Google Patents
Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL68497A0 IL68497A0 IL68497A IL6849783A IL68497A0 IL 68497 A0 IL68497 A0 IL 68497A0 IL 68497 A IL68497 A IL 68497A IL 6849783 A IL6849783 A IL 6849783A IL 68497 A0 IL68497 A0 IL 68497A0
- Authority
- IL
- Israel
- Prior art keywords
- benzoazacycloalkyl
- imidazolidines
- spiro
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL68497A0 true IL68497A0 (en) | 1983-07-31 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL68497A IL68497A0 (en) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (nl) |
| KR (1) | KR840004428A (nl) |
| AT (1) | ATA125383A (nl) |
| AU (1) | AU1395383A (nl) |
| BE (1) | BE896572A (nl) |
| DD (1) | DD209833A5 (nl) |
| DE (1) | DE3315106A1 (nl) |
| DK (1) | DK183583A (nl) |
| ES (1) | ES8405796A1 (nl) |
| FR (1) | FR2525603A1 (nl) |
| GB (1) | GB2133401B (nl) |
| GR (1) | GR78481B (nl) |
| IL (1) | IL68497A0 (nl) |
| IT (1) | IT1167123B (nl) |
| LU (1) | LU84770A1 (nl) |
| MA (1) | MA19783A1 (nl) |
| NL (1) | NL8301476A (nl) |
| NO (1) | NO831473L (nl) |
| OA (1) | OA07412A (nl) |
| PT (1) | PT76595B (nl) |
| SE (1) | SE8302347L (nl) |
| ZA (1) | ZA832927B (nl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| WO2005003096A1 (en) | 2003-06-17 | 2005-01-13 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| ES2571220T3 (es) | 2003-06-17 | 2016-05-24 | Arena Pharm Inc | Clorhidrato de 8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepina |
| US8168624B2 (en) | 2004-12-21 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| CN102627607A (zh) | 2004-12-23 | 2012-08-08 | 艾尼纳制药公司 | 5HT2c受体调节剂组合物和使用方法 |
| CA2646044A1 (en) | 2006-04-03 | 2007-10-25 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
| SG177128A1 (en) | 2006-12-05 | 2012-01-30 | Arena Pharm Inc | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| CN103189053A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 用于体重控制的5-ht2c激动剂的调节释放剂型 |
| WO2012030957A2 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
| MX2013002418A (es) | 2010-09-01 | 2013-08-01 | Arena Pharm Inc | Administracion de lorcaserina a individuos con daño renal. |
| MX2013002422A (es) | 2010-09-01 | 2013-05-17 | Arena Pharm Inc | Sales de lorcaserina con acidos opticamente activos. |
| MY181736A (en) | 2012-10-09 | 2021-01-05 | Arena Pharm Inc | Method of weight management |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT76595B (fr) | 1986-01-21 |
| GR78481B (nl) | 1984-09-27 |
| GB2133401B (en) | 1985-10-23 |
| AU1395383A (en) | 1983-11-03 |
| FR2525603A1 (fr) | 1983-10-28 |
| IT1167123B (it) | 1987-05-13 |
| GB8311508D0 (en) | 1983-06-02 |
| KR840004428A (ko) | 1984-10-15 |
| ES521895A0 (es) | 1984-06-16 |
| PT76595A (fr) | 1983-05-01 |
| SE8302347D0 (sv) | 1983-04-26 |
| NL8301476A (nl) | 1983-11-16 |
| FR2525603B1 (nl) | 1984-09-14 |
| MA19783A1 (fr) | 1983-12-31 |
| ZA832927B (en) | 1984-06-27 |
| DD209833A5 (de) | 1984-05-23 |
| SE8302347L (sv) | 1983-10-28 |
| BE896572A (fr) | 1983-10-26 |
| JPS5910584A (ja) | 1984-01-20 |
| ES8405796A1 (es) | 1984-06-16 |
| OA07412A (fr) | 1984-11-30 |
| DK183583D0 (da) | 1983-04-26 |
| NO831473L (no) | 1983-10-28 |
| ATA125383A (de) | 1986-05-15 |
| DE3315106A1 (de) | 1983-11-03 |
| GB2133401A (en) | 1984-07-25 |
| DK183583A (da) | 1983-10-28 |
| IT8348155A0 (it) | 1983-04-26 |
| LU84770A1 (fr) | 1984-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL67826A0 (en) | Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them | |
| IL69955A (en) | 1-phenyl-2-piperidinoalkanol derivatives,their preparation and pharmaceutical compositions containing them | |
| IL68913A (en) | 3-aminoalkyl-1h-indole-5-alkan-sulphonamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL69157A0 (en) | Fluoromorphinan derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3468030D1 (en) | 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them | |
| IL66099A0 (en) | N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them | |
| IL71475A0 (en) | N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them | |
| IL73951A0 (en) | 2-phenyl-imidazoles,their preparation and pharmaceutical compositions containing them | |
| IL66683A0 (en) | Benzo-heterocycles,their preparation and pharmaceutical compositions containing them | |
| IL64444A0 (en) | 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them | |
| IL68360A0 (en) | Imidazopyrazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL68817A0 (en) | Oxoazetidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL68497A0 (en) | Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them | |
| IL68586A0 (en) | 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them | |
| IL68699A (en) | 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them | |
| IL71419A0 (en) | Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them | |
| IL68496A (en) | 8-heteroarylalkyl-ergoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL72307A0 (en) | Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them | |
| IL62495A0 (en) | Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them | |
| DE3380093D1 (en) | 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them | |
| IL70158A (en) | Tetrahydronaphthalene-carboxamides,their preparation and pharmaceutical compositions comprising them | |
| IL70508A0 (en) | Aralkyltriazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL71110A0 (en) | Azolylmethylcycloalkanes,their preparation and pharmaceutical compositions containing them | |
| IL71661A0 (en) | 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them | |
| IL65177A0 (en) | Fluoroprostacylins,their preparation and pharmaceutical compositions containing them |